Dualpor Injection 10/160 mg
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Genupharm Co., Ltd.
MFDS item code 201900889 · Approved 2019.02.12
This product's status changed to Approval withdrawn on 2023.09.11. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled by monotherapy
This medication is used for patients with essential hypertension who do not achieve adequate blood pressure control with monotherapy using amlodipine or valsartan. It helps to stabilize blood pressure, thereby reducing the risk of cardiovascular diseases.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take the medicine at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before administering this medicine; however, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Older adults aged 65 years or older: Use caution when increasing the dose.
Pediatric patients under 18 years of age: Administration of this medicine is not recommended because its safety and efficacy have not been established.
This medication may cause serious harm to the fetus and newborn if taken during the second and third trimester of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the active ingredients or similar compounds, women who are pregnant or breastfeeding, and individuals with severe kidney or liver dysfunction should not take this medication. Those who are low in sodium or body fluids may experience hypotension, so their condition should be thoroughly checked before taking the medication, and blood pressure and condition should be closely monitored during treatment. Patients with high potassium levels should exercise particular caution when taking this medication with other drugs that can elevate potassium levels, and they should regularly monitor their serum potassium concentration. Patients with renal artery stenosis or those who have recently undergone kidney transplantation may experience worsening renal function while taking this medication. This medication can cause a serious allergic reaction resulting in angioedema, which leads to swelling of the face, lips, or tongue; if such symptoms appear, the medication should be stopped immediately and medical attention sought. Patients with heart failure or post-myocardial infarction should carefully monitor their kidney function and blood pressure while taking this medication, as cardiac-related symptoms such as pulmonary edema may worsen. Possible side effects include dizziness, drowsiness, headache, orthostatic hypotension, cough, dyspepsia, skin rash, edema, and other unusual symptoms. If any abnormal symptoms appear, consult a physician. Caution is advised when driving or operating machinery, as dizziness or fatigue may occur. This medication may interact with other antihypertensives, diuretics, potassium supplements, and some anti-inflammatory drugs; inform healthcare professionals if you are taking any other medications. Women who are pregnant or planning to conceive should not take this medication, and breastfeeding women are also advised to avoid it. This medication is not recommended for children under 18 as its safety and efficacy have not been fully established. Elderly patients can take the same dosage as adults but should follow the advice of healthcare professionals based on their condition. In cases of overdose, serious symptoms such as hypotension may occur, so it’s critical to adhere to the prescribed dose, and if an overdose is suspected, seek immediate medical attention.
Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, orthostatic dizziness, sensory abnormalities, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pain in the pharynx and larynx, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itchiness, joint swelling, low back pain, arthritis, muscle cramps, lethargy, polyuria, nocturia, erectile dysfunction, edema, peripheral edema, facial edema, generalized edema, fatigue, flushing, weakness, facial flushing, hemoglobin decrease, hematocrit decrease, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, hyperkalemia, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste disturbances, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorders, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuroexcitability, sensory loss, Stevens-Johnson syndrome
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature to preserve the drug's efficacy.
Bright yellow rectangular film-coated tablet
28 tablets (14 tablets/Alu-Alu X 2), 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Genupharm Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.